Infliximab efficiency in refractory wegener's granulomatosis (multiple letters) [11]

Rheumatology

Volumn 42, Issue 9, 2003, Pages 1124-1126

  Rozin, A ^a   Lamprecht, P ^b   Voswinkel, J ^b   Gause, A ^b   Gross, W L ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MEGADOSE; FOLLOW UP; HUMAN; LETTER; MAINTENANCE THERAPY; PATHOGENESIS; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; WEGENER GRANULOMATOSIS;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; HUMANS; TUMOR NECROSIS FACTOR-ALPHA; WEGENER GRANULOMATOSIS;

EID: 0141615776     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg295     Document Type: Letter

References (0)